Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
62.41
-0.29 (-0.46%)
Mar 31, 2025, 1:39 PM EDT - Market open

Verona Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
42.26--40-
Upgrade
Other Revenue
0.02-0.46--
Upgrade
Revenue
42.28-0.4640-
Upgrade
Revenue Growth (YoY)
---98.86%--
Upgrade
Cost of Revenue
2.58-0.35--
Upgrade
Gross Profit
39.7-0.1140-
Upgrade
Selling, General & Admin
149.7550.3526.5833.9129.77
Upgrade
Research & Development
40.9716.1139.6563.7836.24
Upgrade
Operating Expenses
190.7266.4766.2397.6866.01
Upgrade
Operating Income
-151.03-66.47-66.12-57.68-66.01
Upgrade
Interest Expense
-23.54-2.06-0.52-0.34-0.04
Upgrade
Interest & Investment Income
15.2612.762.820.010.12
Upgrade
Currency Exchange Gain (Loss)
-0.171.87-3.820.182.06
Upgrade
Other Non Operating Income (Expenses)
---2.25-1.14
Upgrade
EBT Excluding Unusual Items
-159.48-53.9-67.63-55.59-65
Upgrade
Other Unusual Items
-3.65--0.82--
Upgrade
Pretax Income
-163.13-53.9-68.45-55.59-65
Upgrade
Income Tax Expense
10.290.470.25-0.020.15
Upgrade
Net Income
-173.42-54.37-68.7-55.57-65.15
Upgrade
Net Income to Common
-173.42-54.37-68.7-55.57-65.15
Upgrade
Shares Outstanding (Basic)
8279665933
Upgrade
Shares Outstanding (Diluted)
8279665933
Upgrade
Shares Change (YoY)
2.86%19.86%11.81%79.97%149.64%
Upgrade
EPS (Basic)
-2.13-0.69-1.04-0.94-1.98
Upgrade
EPS (Diluted)
-2.16-0.72-1.04-0.94-1.98
Upgrade
Free Cash Flow
-122.78-50.22-59.89-33.27-45.16
Upgrade
Free Cash Flow Per Share
-1.51-0.63-0.91-0.56-1.37
Upgrade
Gross Margin
93.89%-24.45%100.00%-
Upgrade
Operating Margin
-357.22%--14435.81%-144.21%-
Upgrade
Profit Margin
-410.18%--15000.22%-138.92%-
Upgrade
Free Cash Flow Margin
-290.41%--13076.64%-83.17%-
Upgrade
EBITDA
-149.97-65.79-65.48-57.05-65.39
Upgrade
EBITDA Margin
----142.63%-
Upgrade
D&A For EBITDA
1.060.680.640.630.62
Upgrade
EBIT
-151.03-66.47-66.12-57.68-66.01
Upgrade
EBIT Margin
----144.21%-
Upgrade
Revenue as Reported
42.28-0.46--
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q